Latest News about ARVN
Recent news which mentions ARVN
From Benzinga
From Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
August 17, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
3 Stocks To Double Down On In 2022
February 16, 2022
From Benzinga
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
February 16, 2022
From Motley Fool
Arvinas Highlights New ARV-110 Data In Prostate Cancer Patients
February 15, 2022
Tickers
ARVN
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2022
February 10, 2022
From Benzinga
2 Exciting Trends That Could Shape Healthcare's Future
February 10, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022
January 19, 2022
From Benzinga
5 Stocks Insiders Are Selling
December 17, 2021
From Benzinga
Arvinas, Pfizer's ARV-471 Shows Clinical Benefit Rate Of 40% In Pretreated Breast Cancer Patients
December 10, 2021
From Benzinga
The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares
December 10, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
December 07, 2021
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
4 Stocks Insiders Are Selling
November 16, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.